30.01.2015 Views

kontinuita - Komunálna Poisťovňa

kontinuita - Komunálna Poisťovňa

kontinuita - Komunálna Poisťovňa

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

NOTES TO<br />

THE FINANCIAL<br />

STATEMENTS<br />

as the current contractual interest rate. The Company<br />

may also determine the amount of the impairment loss<br />

as the difference between the financial asset’s fair<br />

value set on the basis of its market price and financial<br />

asset’s carrying amount.<br />

If, in a subsequent period, the amount of the impairment<br />

loss decreases and this decrease is objectively<br />

related to an event that had occurred after the impairment<br />

was recognized (such as improved credit rating of<br />

the debtor or issuer), the reported impairment loss is<br />

reversed by adjusting the allowance account. The<br />

amount of the reversal is recognized in the income<br />

statement.<br />

(ii) Financial assets carried at fair value<br />

The Company assesses at each balance sheet date<br />

whether there is an objective indication that a financial<br />

asset is impaired. In the case of equity securities classified<br />

as available for sale, a prolonged or significant<br />

diminution in the fair value of the security below its<br />

cost is taken into account. If any such evidence exists<br />

for financial assets available for sale, the cumulative<br />

loss – measured as the difference between the acquisition<br />

cost and current fair value, less any impairment<br />

loss on the financial asset previously recognized in<br />

profit or loss – is removed from valuation variances in<br />

equity and recognized in the income statement. Impairment<br />

losses on equity instruments that are recognized<br />

in the income statement are not reversed to the<br />

income statement. The impairment loss on debt securities<br />

is reversed through the income statement if, in a<br />

subsequent period, the fair value of a debt instrument<br />

increases and this increase objectively relates to an<br />

event that had occurred after the impairment loss was<br />

recognized in profit or loss.<br />

(iii) Impairment of other non-financial assets<br />

Assets that have an indefinite useful life are not amortized;<br />

however, they are tested for impairment every<br />

year. Assets that are subject to amortization are reviewed<br />

for impairment whenever events or changes in<br />

circumstances indicate that the carrying amount may<br />

not be recoverable. An impairment loss is recognized<br />

at the amount by which the asset’s carrying amount<br />

exceeds its recoverable amount. The recoverable<br />

amount is the higher of an asset’s fair value less costs<br />

to sell and value in use. For the purposes of assessing<br />

impairment, assets are grouped at the lowest levels for<br />

which separately identifiable cash flows (cash-generating<br />

units) exist. Impaired non-monetary assets other<br />

than goodwill are reviewed at each balance sheet date<br />

to establish whether or not the impairment can be reversed.<br />

2.7 Offsetting financial instruments<br />

Financial assets and liabilities are offset and the net<br />

amount is reported in the balance sheet only when<br />

there is a legally enforceable right to offset the recognized<br />

amounts and there is an intention to settle on a<br />

net basis, or to realize the asset and settle the liability<br />

simultaneously.<br />

2.8 Cash and cash equivalents<br />

Cash and cash equivalents include cash in hand, sight<br />

deposits with banks, and other high-liquid investments<br />

with original maturity up to three months.<br />

2.9 Share capital<br />

Ordinary shares are classified as share capital. Additional<br />

costs directly attributable to the issue of new equity<br />

securities are shown in equity as a deduction, net<br />

of tax, from the proceeds.<br />

2.10 Insurance and investment contracts<br />

The Company concludes contracts that transfer insurance<br />

risk or financial risk or both.<br />

Contracts in which the Company assumes significant insurance<br />

risk of a third party (policyholder) and agrees<br />

KONTINUITA ANNUAL REPORT 109

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!